Evidence map›Paper›PMID 40733106›Full record

ReviewPharmaceutics2025

Patent-Based Technological Overview of Propolis-Cyclodextrin Inclusion Complexes with Pharmaceutical Potential.

Salvana Costa, Ighor Costa Barreto, Nataly Gama, Kathylen Santos, Cleomárcio Miguel de Oliveira, Isabela Silva Costa, Monique Vila Nova, Ruane Santos, Arthur Borges, José Marcos Teixeira de Alencar Filho and 1 more

Abstract readReview
In one paragraph

Review in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Salvana CostaInstitute of Pharmaceutical Science, Federal University of Alagoas, Maceio 57072-970, Alagoas, Brazil.
Ighor Costa BarretoSuperintendency of Environment and Infrastructure, Federal University of Bahia, Salvador 40170-110, Bahia, Brazil.
Nataly GamaInstitute of Pharmaceutical Science, Federal University of Alagoas, Maceio 57072-970, Alagoas, Brazil.ORCID 0009-0004-2396-0618
Kathylen SantosInstitute of Pharmaceutical Science, Federal University of Alagoas, Maceio 57072-970, Alagoas, Brazil.
Cleomárcio Miguel de OliveiraPharmacy Department, Irecê College, Irecê 40900-000, Bahia, Brazil.ORCID 0009-0003-3278-0283
Isabela Silva CostaPharmacy Department, Irecê College, Irecê 40900-000, Bahia, Brazil.ORCID 0009-0001-1588-3729
Monique Vila NovaInstitute of Pharmaceutical Science, Federal University of Alagoas, Maceio 57072-970, Alagoas, Brazil.
Ruane SantosInstitute of Pharmaceutical Science, Federal University of Alagoas, Maceio 57072-970, Alagoas, Brazil.
Arthur BorgesTechnology Center, Federal University of Alagoas, Maceio 57072-970, Alagoas, Brazil.ORCID 0000-0001-5934-2652
José Marcos Teixeira de Alencar FilhoPharmacy College, Federal University of Bahia, Salvador 40170-110, Bahia, Brazil.ORCID 0000-0001-8878-8557
Ticiano Gomes do NascimentoInstitute of Pharmaceutical Science, Federal University of Alagoas, Maceio 57072-970, Alagoas, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cyclodextrinsdrug delivery systemspolysaccharidespropolis

Identifiers

PMID40733106
PMCPMC12300310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.